Search

Author/Creator Parkes, Eileen

1. 408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors. (9th November 2020)

Authors:
Harrington, Kevin; Parkes, Eileen; Weiss, Jared; Ingham, Mathew; Cervantes, Andrés; Calvo, Emiliano; Riese, Matthew; Klinkhardt, Ute; Sikken, Patricia; Schmohl, Michael; Garralda, Elena
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A248
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Review of applications of high-throughput sequencing in personalized medicine: barriers and facilitators of future progress in research and clinical application. (14th June 2019)

Authors:
Lightbody, Gaye; Haberland, Valeriia; Browne, Fiona; Taggart, Laura; Zheng, Huiru; Parkes, Eileen; Blayney, Jaine K
Journal:
Briefings in bioinformatics
Issue:
Volume 20:Number 5(2020)
Page Start:
1795
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗